Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Menta “Steve” Wallace shows a bottle of daraxonrasib, Revolution Medicines’ pancreatic cancer drug, at his home in The…
Stocks making the biggest moves midday: ORCL, CAG, CRM, GS
Here are some of the stocks making headlines in midday trading. Oracle — Shares of the cloud platform…
Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial
Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer…